Great work by Selma Bekri, PhD and The Tisch Cancer Institute #mmsm MM Center of Excellence clinical research team in collaboration with David Coffey MD Sylvester Comprehensive Cancer Center.

New #JITC article: Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma bit.ly/3JjMsvl Donna Catamero Hearn Jay Cho MD, PhD

George Mulligan (Multiple Myeloma RF) discusses MMRF clinical and translational research strategy

#iwMyeloma24 #HemOnc #Myeloma #MultipleMyeloma Multiple Myeloma RF

Join us on 4/24 for a FREE patient webinar on autologous stem cell transplantation (ASCT). #Myeloma Drs. Sergio Giralt and David H. Vesole, will discuss why ASCT is used in treating #multiplemyeloma . Don’t miss out – register today: ow.ly/BabL50RcBvs

Memorial Sloan Kettering Cancer Center #mmsm

The MMRF Research Fellow Award Program supports early career researchers in multiple myeloma with $150K over 2 years. Meet Dr. Holly Lee, a 2023 awardee who published a review on bispecific antibodies in myeloma. Read about her journey and research impact: themmrf.org/mmrf-blogs/bre…

Today, US FDA held an ODAC meeting to debate MRD as an endpoint to support accelerated approval in #myeloma clinical trials. Two groups (Sylvester Comprehensive Cancer Center and i2TEAMM) presented retrospective data from clinical trials that measured MRD. Final vote was 12-0 in favor.

Calling all health care professionals in #myeloma ! 📢 We are excited to announce a NEW CME activity you can participate in. In this activity, experts address key questions about BCMA-targeted therapy for #RRMM . Start for FREE today: ow.ly/5R3H50RcBcr

📢 Join us at the Miami Myeloma MRD Virtual Meeting 2024 on May 9th, 9am – 1pm EST! 🎓 Explore the latest advancements in multiple myeloma research with leading experts. Don’t miss out on this interactive workshop chaired by C. Ola Landgren, M.D.. Register now: vjhemonc.com/feature/miami-…

ASCT is standard-of-care for newly diagnosed, eligible #myeloma patients. While you are undergoing ASCT, you will be carefully monitored, and supportive care will be provided to minimize and manage side effects.

Download our ASCT booklet to learn more: ow.ly/8H7r50R72vh

.U.S. FDA and Bristol Myers Squibb announce approval of the CAR T-cell therapy Abecma for triple class (PI, iMiD, CD38 antibody) exposed relapsed/refractory #myeloma patients after 2 or more prior lines of therapy #mmsm news.bms.com/news/corporate…

.U.S. FDA approves CAR T-cell therapy Carvykti for treatment of relapsed/refractory #myeloma patients who have received at least one prior line of therapy which included a PI and IMid, and are refractory to Revlimid. #mmsm

onclive.com/view/fda-appro…

Gratitude post to Shaji Kumar for his generous contribution to the fundraising efforts of the #woMMen trekking Peru, raising funds for International Myeloma Foundation
fundraise.myeloma.org/campaign/women…

As her transplanter, it should be my decision on when I take her to transplant. And while you continue to deny her 2 more cycles DRVD, the pt’s light chains are increasing.

- #MedTwitter please amplify this!
#mmsm

Within 2 weeks of the transplant, newly formed blood cells can be detected in your blood. A successful transplant results in the growth of healthy red blood cells, white blood cells, & platelets. For more, watch our High Impact Topic (HIT) video on ASCT: ow.ly/tXqz50R72nP

April is #NationalMinorityCancerAwarenessMonth . Every #myeloma patient deserves the best possible outcome. This belief is rooted in the MMRF’s mission to accelerate a cure for each AND every patient. Learn more about our efforts: ow.ly/EA8l50R4s8l

We're on a mission to change this stat! 💔 We are committed to accelerating the development of novel therapies, driving optimal & more personalized treatment approaches, and empowering #myeloma patients & the community. Donate today to support our mission: ow.ly/3v7750R3LE7

Sign up to join the latest event in Cure Multiple Myeloma Corporation's Ask the Doctor Breakfast Series. On 4/2 Dr. Craig E. Cole will be their featured speaker. These discussions are designed with patients in mind. To learn more and register: cmmc.wildapricot.org/event-5664268

Save the date 💌 for our Multiple Myeloma Community Summit on April 5th in partnership with @NOW_INCLUDED! Join us in Atlanta, GA to learn about multiple #myeloma & meet people like Tamara (pictured below), a myeloma thriver for 13 years. Register today: ow.ly/3CfK50R1JLX

Did you know? 👇💡

Learn about multiple #myeloma here: ow.ly/iri250QZc8G #MyelomaAwarenessMonth

In this article from The ASCO Post, learn about the journey of MMRF Founder Kathy Giusti, as she shares her story of resilience and advocacy in the fight against cancer. Learn how patients can take control of their disease and fear cancer less. ascopost.com/issues/march-2…